123 related articles for article (PubMed ID: 17416350)
1. Glucose regulation of CDK7, a putative thiol related gene, in experimental diabetic nephropathy.
Malik AN; Rossios C; Al-Kafaji G; Shah A; Page RA
Biochem Biophys Res Commun; 2007 May; 357(1):237-44. PubMed ID: 17416350
[TBL] [Abstract][Full Text] [Related]
2. Glucose regulation of beta-defensin-1 mRNA in human renal cells.
Malik AN; Al-Kafaji G
Biochem Biophys Res Commun; 2007 Feb; 353(2):318-23. PubMed ID: 17187760
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of beta defensin-1 mRNA in diabetic kidneys of GK rats.
Page RA; Malik AN
Biochem Biophys Res Commun; 2003 Oct; 310(2):513-21. PubMed ID: 14521940
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia induces elevated expression of thyroid hormone binding protein in vivo in kidney and heart and in vitro in mesangial cells.
Al-Kafaji G; Malik AN
Biochem Biophys Res Commun; 2010 Jan; 391(4):1585-91. PubMed ID: 20018174
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
Shahni R; Gnudi L; King A; Jones P; Malik AN
Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats.
Vlachojannis GJ; Scholz-Pedretti K; Fierlbeck W; Geiger H; Pfeilschifter J; Kaszkin M
Clin Nephrol; 2005 May; 63(5):356-67. PubMed ID: 15909595
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus increases endothelin-1 gene transcription in rat kidney.
Hargrove GM; Dufresne J; Whiteside C; Muruve DA; Wong NC
Kidney Int; 2000 Oct; 58(4):1534-45. PubMed ID: 11012888
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemic levels in early stage of diabetic nephropathy affect differentially renal expression of claudins-2 and -5 by oxidative stress.
Rosas-Martínez L; Rodríguez-Muñoz R; Namorado-Tonix MDC; Missirlis F; Del Valle-Mondragón L; Sánchez-Mendoza A; Reyes-Sánchez JL; Cervantes-Pérez LG
Life Sci; 2021 Mar; 268():119003. PubMed ID: 33417957
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP
Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
11. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
12. Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics.
Larochelle S; Batliner J; Gamble MJ; Barboza NM; Kraybill BC; Blethrow JD; Shokat KM; Fisher RP
Nat Struct Mol Biol; 2006 Jan; 13(1):55-62. PubMed ID: 16327805
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of CDK7-associated human MAT1, a cyclin-dependent kinase-activating kinase (CAK) assembly factor.
Yee A; Nichols MA; Wu L; Hall FL; Kobayashi R; Xiong Y
Cancer Res; 1995 Dec; 55(24):6058-62. PubMed ID: 8521393
[TBL] [Abstract][Full Text] [Related]
14. Decrease of bone morphogenetic protein-7 (BMP-7) and its type II receptor (BMP-RII) in kidney of type 1-like diabetic rats.
Yeh CH; Chang CK; Cheng MF; Lin HJ; Cheng JT
Horm Metab Res; 2009 Aug; 41(8):605-11. PubMed ID: 19440953
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of human CDK7 and its protein recognition properties.
Lolli G; Lowe ED; Brown NR; Johnson LN
Structure; 2004 Nov; 12(11):2067-79. PubMed ID: 15530371
[TBL] [Abstract][Full Text] [Related]
16. Nop-7-associated 2 (NSA2), a candidate gene for diabetic nephropathy, is involved in the TGFβ1 pathway.
Shahni R; Czajka A; Mankoo BS; Guvenel AK; King AJ; Malik AN
Int J Biochem Cell Biol; 2013 Mar; 45(3):626-35. PubMed ID: 23220173
[TBL] [Abstract][Full Text] [Related]
17. Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
Shin SJ; Chung S; Kim SJ; Lee EM; Yoo YH; Kim JW; Ahn YB; Kim ES; Moon SD; Kim MJ; Ko SH
PLoS One; 2016; 11(11):e0165703. PubMed ID: 27802313
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the cyclin-dependent kinases at the beginning of human cytomegalovirus infection specifically alters the levels and localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and cdk7 at the viral transcriptosome.
Kapasi AJ; Spector DH
J Virol; 2008 Jan; 82(1):394-407. PubMed ID: 17942543
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin-mimetic peptide CB3 lowers MAPKinase activity in the Zucker rat brain.
Cohen-Kutner M; Khomsky L; Trus M; Ben-Yehuda H; Lenhard JM; Liang Y; Martin T; Atlas D
Redox Biol; 2014; 2():447-56. PubMed ID: 24624334
[TBL] [Abstract][Full Text] [Related]
20. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
Chen N; Song S; Yang Z; Wu M; Mu L; Zhou T; Shi Y
J Diabetes Complications; 2021 Dec; 35(12):108050. PubMed ID: 34600826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
